{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:48:01Z","timestamp":1791110881488,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11605-021-05073-3","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T16:02:32Z","timestamp":1625846552000},"page":"2649-2659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"Andrea","family":"Di Giorgio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Santullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Attalla El Halabieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lodoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Abatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alessandra","family":"Calegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-021-05073-3_bb0010","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0015","doi-asserted-by":"crossref","unstructured":"Go\u00e9r\u00e9 D, Sourrouille I, Gelli M, Benhaim L, Faron M, Honor\u00e9 C. Peritoneal Metastases from Colorectal Cancer: Treatment Principles and Perspectives. Surg Oncol Clin N Am 2018;27:563\u2013583. https:\/\/doi.org\/10.1016\/j.soc.2018.02.011.","DOI":"10.1016\/j.soc.2018.02.011"},{"key":"10.1007\/s11605-021-05073-3_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: A pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0025","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis from Colorectal Cancer: A Multi-Institutional Study","volume":"22","author":"Glehen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0035","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0040","doi-asserted-by":"crossref","unstructured":"Yoshino T, Arnold D, Taniguchi H, Pentheroudakis G, Yamazaki K, Xu R-H, Kim TW, Ismail F, Tan IB, Yeh K-H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol Off J Eur Soc Med Oncol 2018; 29:44\u201370. https:\/\/doi.org\/10.1093\/annonc\/mdx738.","DOI":"10.1093\/annonc\/mdx738"},{"key":"10.1007\/s11605-021-05073-3_bb0045","unstructured":"Version 2.2020 (03 March 2020). Colon Cancer. Clinical Practice Guidelines in Oncology (NCCN Guidelines) n.d."},{"key":"10.1007\/s11605-021-05073-3_bb0050","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0055","first-page":"245","article-title":"Hyperthermic Intraoperative Intreperitoneal Chemotherapy (HIIC) With Mitomycin C","volume":"5","author":"Sugarbaker","year":"1996","journal-title":"Surg Technol Int"},{"key":"10.1007\/s11605-021-05073-3_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-0-387-48993-3_15","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"2007","journal-title":"Perit Carcinomatosis A Multidiscip Approach"},{"key":"10.1007\/s11605-021-05073-3_bb0065","doi-asserted-by":"crossref","unstructured":"Rotolo S, Di Giorgio A, Santullo F, Attalla El Halabieh M, Lodoli C, Abatini C, et al. Cytoreductive surgery and mitomycin C hyperthermic intraperitoneal chemotherapy with CO2 recirculation (HIPEC-CO2) for colorectal cancer peritoneal metastases: analysis of short-term outcomes. Updates Surg 2021. https:\/\/doi.org\/10.1007\/s13304-021-01034-2.","DOI":"10.1007\/s13304-021-01034-2"},{"key":"10.1007\/s11605-021-05073-3_bb0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"key":"10.1007\/s11605-021-05073-3_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications: Five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-021-05073-3_bb0080","doi-asserted-by":"crossref","first-page":"55657","DOI":"10.18632\/oncotarget.17497","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: A systematic review and meta-analysis of current evidence","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1007\/s11605-021-05073-3_bb0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1245\/s10434-016-5712-3","article-title":"The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review","volume":"24","author":"Waite","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric french study","volume":"28","author":"Elias","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10434-004-1167-z","article-title":"Long-term survival of peritoneal carcinomatosis of colorectal origin","volume":"12","author":"Verwaal","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","article-title":"Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer","volume":"23","author":"Faron","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002800051093","article-title":"Successful management of microscopic residual disease in large bowel cancer","volume":"43","author":"Sugarbaker","year":"1999","journal-title":"Cancer Chemother Pharmacol Suppl"},{"key":"10.1007\/s11605-021-05073-3_bb0110","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","article-title":"Extent of Colorectal Peritoneal Carcinomatosis: Attempt to Define a Threshold Above Which HIPEC Does Not Offer Survival Benefit: A Comparative Study","volume":"22","author":"Go\u00e9r\u00e9","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jamaoncol.2016.4227","article-title":"Prognostic survival associated with left-sided vs right-sided colon cancer a systematic review and meta-analysis","volume":"3","author":"Petrelli","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000443644","article-title":"Right sided colon cancer as a distinct histopathological subtype with reduced prognosis","volume":"33","author":"Nitsche","year":"2016","journal-title":"Dig Surg"},{"key":"10.1007\/s11605-021-05073-3_bb0125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.29129","article-title":"Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?","volume":"121","author":"Price","year":"2015","journal-title":"Cancer"},{"key":"10.1007\/s11605-021-05073-3_bb0130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1245\/s10434-017-6264-x","article-title":"The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer","volume":"25","author":"Creasy","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejso.2017.10.218","article-title":"Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases","volume":"44","author":"Dupr\u00e9","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0140","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1245\/s10434-019-07255-5","article-title":"Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?","volume":"26","author":"Kelly","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2017.07.016","article-title":"Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes","volume":"84","author":"Stintzing","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1007\/s11605-021-05073-3_bb0150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1054\/bjoc.2001.1964","article-title":"Kirsten ras mutations in patients with colorectal cancer: The \u201cRASCAL II\u201d study","volume":"85","author":"Andreyev","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1007\/s11605-021-05073-3_bb0155","first-page":"2002","article-title":"Velculescu VE","volume":"418","author":"Rajagopalan","year":"2002","journal-title":"RAF\/ RAS oncogenes and mismatch-repair status"},{"key":"10.1007\/s11605-021-05073-3_bb0160","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","article-title":"Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: Results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial","volume":"28","author":"Roth","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0165","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1093\/annonc\/mdu464","article-title":"Prognostic value of KRAS mutations in stage III colon cancer: Post hoc analysis of the PETACC8 phase III trial dataset","volume":"25","author":"Blons","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0170","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/annonc\/mdq258","article-title":"The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients","volume":"21","author":"Fari\u00f1a-Sarasqueta","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0175","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2217\/pgs.15.140","article-title":"BRAF in metastatic colorectal cancer: the future starts now","volume":"16","author":"Orlandi","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1007\/s11605-021-05073-3_bb0180","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/annonc\/mdx401","article-title":"BRAF mutant colorectal cancer: Prognosis, treatment, and new perspectives","volume":"28","author":"Sanz-Garcia","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0185","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","article-title":"Mutations of RAS\/RAF proto-oncogenes impair survival after cytoreductive surgery and HIPEC for peritoneal metastasis of colorectal origin","volume":"268","author":"Schneider","year":"2018","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-021-05073-3_bb0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1245\/s10434-019-07452-2","article-title":"Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC","volume":"27","author":"Graf","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1007\/s11605-021-05073-3_bb0195","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"10.1007\/s11605-021-05073-3_bb0200","doi-asserted-by":"crossref","unstructured":"Ubink I, van Eden WJ, Snaebjornsson P, Kok NFM, van Kuik J, van Grevenstein WMU, Lacl\u00e9 MM, Sanders J, Fijneman RJA, Elias SG, et al. Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.Br J Surg 2018;105:e204\u2013e211. https:\/\/doi.org\/10.1002\/bjs.10788.","DOI":"10.1002\/bjs.10788"},{"key":"10.1007\/s11605-021-05073-3_bb0205","doi-asserted-by":"crossref","first-page":"411","DOI":"10.6004\/jnccn.2017.0038","article-title":"Right versus left colon cancer biology: Integrating the consensus molecular subtypes","volume":"15","author":"Lee","year":"2017","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"10.1007\/s11605-021-05073-3_bb0210","first-page":"149","article-title":"Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location","volume":"18","author":"Cannon","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"10.1007\/s11605-021-05073-3_bb0215","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3892\/or.2016.5323","article-title":"High concordance rate of KRAS\/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases","volume":"37","author":"Fujiyoshi","year":"2017","journal-title":"Oncol Rep"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-021-05073-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-021-05073-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X2300817X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X2300817X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-021-05073-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:04:20Z","timestamp":1761077060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X2300817X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1091255X2300817X"],"URL":"https:\/\/doi.org\/10.1007\/s11605-021-05073-3","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-021-05073-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}